The Cleveland Cord Blood Center (CCBC), a not-for-profit 501(c)(3), is an independent public cord blood bank serving as a leader in the collection, processing, storage and distribution of quality cord blood stem cell units for transplantation in patients with life threatening disorders such as leukemia, lymphoma and immune system disorders. The Center is one of only eight FDA-approved cord blood Centers in the U.S.
Cleveland Cord Blood Center researchers are exploring umbilical cord blood’s expanding untapped potential as a cell therapy treatment, with several research partners working collaboratively with the CCBC team. In turn, several initiatives are underway through affiliated social enterprises.
The Cleveland Cord Blood Center was founded in 2008 by Mary J. Laughlin, M.D., who performed one of the world’s first successful umbilical cord blood stem cell transplants on an adult leukemia patient in 1995.
The Center strives to foster greater awareness of the life-giving and lifesaving potential that cord blood stem cells hold.
The broad diversity in the genetic and ethnic backgrounds of families in Atlanta, Cleveland and San Francisco donating cord blood to the Cleveland Cord Blood Center supports an inventory of cord blood units for patients of African American, Latino and Asian descent, for whom well-matched stem cell grafts are not generally available in the adult donor registry.